Skip to content
Subscriber Only

Bristol-Myers, McDonald’s, Budweiser: Intellectual Property

The Medicines Patent Pool and Bristol-Myers Squibb Co. signed an agreement that will increase access to Atazanavir, a drug to treat AIDS, in 110 developing nations.

The Medicines Patent Pool, an organization backed by the United Nations and created to increase access to AIDS drugs in poorer countries, said in a statement the agreement is the first of its kind covering a second-line therapy preferred by the World Health Organization. According to WHO figures, more than 1 million people will be on second-line treatment by 2016, with many more needing access to this class of drugs.